Developer docs
API playgroundTry for free, no card

Search company profiles

Convergent Research

Full company profile

uuid000378r

Namestring
Convergent Research
Legal namestring
Convergent Research, LLC
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Convergent Research is a 501(c)(3) non-profit science studio founded in 2021 by Adam Marblestone (CEO) and Anastasia Gamick (President), headquartered in Cambridge, Massachusetts. The organization pioneered the Focused Research Organization (FRO) model — a time-bound, technically ambitious non-profit structure that assembles teams of 10-30+ engineers and scientists to produce high-impact public goods (tools, datasets, platforms) that unblock progress in specific scientific fields over 3-7 year horizons. Convergent identifies scientific bottlenecks through systematic technical roadmapping, matches funders with founding teams, incubates FROs, and provides ongoing governance and operational support as a parent non-profit.

The organization has launched 10 FROs since 2021 spanning brain connectomics (E11 Bio, Forest Neurotech), proteomics (Parallel Squared Technology Institute), microbial cultivation (Cultivarium), pharmacology (EvE Bio), forensic immunology (Imprint), formal mathematics verification (Lean FRO), ocean carbon removal MRV ([C]Worthy), and UK-based brain connectivity and ecological intelligence (Meridial, Echo Labs). These FROs produce public goods including open-source software (plexDIA, Volara, Lean proof assistant, fUSI-BIDS), public datasets (EvE Bio Pharmome Data Portal, Cultivarium Organism Portal), and scientific infrastructure. Convergent's revenue model is philanthropic grant funding from 30+ individuals and institutions, with cumulative funding of approximately $400 million since inception. Funding tiers range from $10k for roadmapping support to $10M+ for anchoring new FROs, with FROs typically receiving initial grants of $20-50 million each.

Short descriptiontext

Convergent Research is a 501(c)(3) non-profit science studio that designs, launches, and operates Focused Research Organizations (FROs) — time-bound teams producing public-good tools, datasets, and platforms to unblock progress in specific scientific fields, funded by philanthropic grants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
scientific research infrastructure, focused research organizations, nonprofit science incubation, open-source scientific tools, public goods research
Industry4 codes
1Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryYes
2Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
CodeHLAGANAIPrimaryNo
3Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
CodeHLAGAAALPrimaryNo
4Sustainability & ESG Consulting
CodeBPAHACAKPrimaryNo
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Scientific Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Philanthropic/Grant Funding
TypeLicensing Royalties
Description

Convergent Research is a 501(c)(3) non-profit organization that raises funding from individuals and institutions to support FRO creation. Funding tiers include $10M+ to anchor a new FRO, $1M+ to co-fund an existing FRO with anchor donor, and $10k+ to support scientific roadmapping and FRO sourcing programs.

convergentresearch.org
2FRO Operational Support
TypeProfessional Services
Description

As a parent non-profit, Convergent provides subsidiary FROs with governance and critical operations support. FROs may generate revenue through product sales, perpetual endowment as foundation, or commercialization by licensing to companies.

convergentresearch.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Convergent Research is a nonprofit science studio that creates, funds, and operates Focused Research Organizations (FROs) — time-bound, technically ambitious nonprofit subsidiaries that build tools, datasets, and platforms as public goods to unblock scientific progress. The parent organization provides systematic technical roadmapping, founder-funder matchmaking, incubation, governance, and shared operational support to 10+ FROs across neuroscience, proteomics, microbiology, formal mathematics, immunology, climate science, and related fields.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Nearly $400 million secured from 30+ funders since 2021
+2 more records
Product overview1 text field

Convergent Research is a nonprofit science studio that pioneers the Focused Research Organization (FRO) model as a new operating system for science. Rather than a single unified product, Convergent Research serves as an incubator that designs, launches, and operates multiple subsidiary FROs (currently 10 active projects including Cultivarium, [C]Worthy, E11 Bio, EvE Bio, Forest Neurotech, Imprint, Lean FRO, and Parallel Squared Technology Institute). Each FRO is a time-bound nonprofit startup focused on building specific scientific infrastructure, tools, datasets, or platforms to remove bottlenecks in a particular scientific domain. Convergent provides operational backbone, governance, and fundraising support while FRO teams maintain technical focus and autonomy.

Product and service11 records
1Cultivarium
CategoryFocused Research Organization (FRO) — Microbiology
Description

A bioengineering Focused Research Organization (FRO) that helps labs harness microorganisms through a predictive high-throughput culturing platform, cross-species genetic toolkit, and Microbe Information Hub indexing 170,000+ microbes. It produces public-good microbial cultivation tools and organism data for the scientific community.

2E11 Bio
CategoryFocused Research Organization (FRO) — Neuroscience
Description

A Focused Research Organization (FRO) building scalable technologies for circuit mapping at single-cell resolution in mammalian brains using PRISM technology, which combines protein barcoding, advanced microscopy, and machine learning for connectomics. It releases tools such as PRISMA (self-correcting neuron tracing) as open-source public goods.

3Parallel Squared Technology Institute (PTI)
CategoryFocused Research Organization (FRO) — Proteomics
Description

A Focused Research Organization (FRO) accelerating single-cell proteomics using novel mass tags and multiplexing approaches to enable researchers to study thousands of individual cells in parallel. Produces open-source mass spectrometry tools and workflows (e.g., plexDIA, Volara) as public goods for proteomics researchers.

4Forest Neurotech
CategoryFocused Research Organization (FRO) — Neuroscience
Description

A Focused Research Organization (FRO) developing wearable whole-brain ultrasound technology for functional imaging and neuromodulation in humans, enabling non-invasive brain-computer interfaces. Releases tools such as fUSI-BIDS Pydantic as open-source public goods for neuroscience researchers.

5Lean FRO
CategoryFocused Research Organization (FRO) — Formal Mathematics and Verification
Description

A Focused Research Organization (FRO) working to make formal verification more accessible through the Lean programming language and proof assistant, with focus on scalability, usability, and proof automation. Releases the Lean proof assistant and a library of use cases as open-source public goods for the formal mathematics and verification community.

6Imprint
CategoryFocused Research Organization (FRO) — Immunology
Description

A Focused Research Organization (FRO) for forensic immunology, building experimental and machine learning tools to decode immune memory and identify hidden causes of chronic diseases including autoimmune, neurological, and psychiatric disorders. Located in New York.

7EvE Bio
CategoryFocused Research Organization (FRO) — Pharmome / Drug Discovery
Description

A Focused Research Organization (FRO) mapping the pharmome by identifying all unintended targets (off-targets) of small-molecule pharmaceutical drugs through systematic drug-target assay results. Releases the Pharmome Data Portal as a CC BY-NC-SA-licensed public dataset updated by rolling releases.

8[C]Worthy
CategoryFocused Research Organization (FRO) — Climate Science / Ocean Carbon Removal
Description

A Focused Research Organization (FRO) building open-source, science-backed tools for ocean-based carbon dioxide removal (CDR), including the C-Star platform for Monitoring, Reporting, and Verification (MRV) and the Ocean CDR Atlas. Works with commercial CDR companies, registries, and buyers.

9Meridial
CategoryFocused Research Organization (FRO) — Neuroscience (UK)
Description

A UK-based Focused Research Organization (FRO) building scientific infrastructure for living-brain connectivity mapping, launched in 2026 in partnership with the UK's ARIA agency.

10Echo Labs
CategoryFocused Research Organization (FRO) — Ecological Intelligence (UK)
Description

A UK-based Focused Research Organization (FRO) building scientific infrastructure for ecological intelligence, launched in 2026 in partnership with the UK's ARIA agency.

11Focused Research Organization (FRO) Model and Incubation Service
CategoryScience Studio Incubation Service
Description

Convergent Research's core offering: a systematic process for identifying scientific bottlenecks through technical roadmapping, matching funders and founders, and providing governance and operational support to launch time-bound, technically ambitious nonprofit FROs that produce high-impact public goods over 3-7 years. The methodology is itself the product that Convergent sells/delivers to scientists and funders.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-09
Description

Convergent Research announced collaboration with UK-based ARIA as an Activation Partner to launch Focused Research Organizations (FROs) for science and technology in the UK ('FROST UK'). The partnership involves launching an open call for FRO proposals in spring 2025, selecting proposers for the Founder in Residence (FiR) program, and incubating at least one FRO in the UK. Convergent will work with ARIA's Program Directors to identify bottlenecks within their opportunity spaces.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Palo Alto-based non-profit research organization founded in 2021 that runs large-scale, long-horizon team science initiatives with unrestricted funding from a small group of philanthropists (Patron, Cox, Pritzker). Closely comparable in mission, structure, and operating model to Convergent's FRO concept.

TypeDirect peer
Description

Philanthropic venture led by Eric and Wendy Schmidt that funds ambitious science and talent programs, including Convergent itself. Directly comparable in deploying philanthropic capital toward frontier science infrastructure and scientist-led ventures.

TypeDirect peer
Description

UK government R&D agency modeled on ARPA that funds high-risk, high-reward science through Program Directors. Active partner of Convergent for FROST UK and uses similar bottleneck-mapping and milestone-based funding approaches.

TypeDirect peer
Description

Non-profit focused on funding and scaling ambitious, unconventional scientific research and infrastructure, founded by Jan Chipchase. Directly comparable in operating in the gap between traditional academia, startups, and government science funding.

TypeDirect peer
Description

Non-profit policy and science organization that operates applied science projects and translates research into public-good outputs. Shares Convergent's model of housing technical programs under a non-profit umbrella to deliver public-impact science.

TypeBroad incumbent
Description

Large, established non-profit biomedical research organization that funds and operates labs to produce scientific public goods. Comparable in mission to produce research as public good, but operates at much larger scale and focuses exclusively on biomedical research.

TypeDirect peer
Description

Non-profit research company founded by Patrick Collison that pursues high-risk, high-reward biology with a public-good orientation. Comparable in operating time-bound research programs with philanthropic funding and open science outputs.

TypeBroad incumbent
Description

Major philanthropic funder backing high-impact, long-horizon science causes including Convergent itself. Comparable as a large-scale science-philanthropy organization but operates as a grantmaker rather than as an operating R&D entity.

TypeEmerging player
Description

Non-profit philanthropy organization led by Tom Kalil (Convergent board chair) focused on increasing R&D investment for scientific and technological progress. Conceptually adjacent in deploying philanthropic capital toward science infrastructure priorities.

TypeBroad incumbent
Description

Paul Allen-founded non-profit research institutes (AI, brain science, cell science) that operate large team-science programs producing public-good datasets and tools. Comparable in mission and open-data outputs but is larger, longer-established, and domain-focused rather than diversified like Convergent's FRO portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Convergent Research

Scientific Research Servicesconvergentresearch.org

Convergent Research is a 501(c)(3) non-profit science studio that designs, launches, and operates Focused Research Organizations (FROs) — time-bound teams producing public-good tools, datasets, and platforms to unblock progress in specific scientific fields, funded by philanthropic grants.

What Convergent Research does

Convergent Research is a 501(c)(3) non-profit science studio founded in 2021 by Adam Marblestone (CEO) and Anastasia Gamick (President), headquartered in Cambridge, Massachusetts. The organization pioneered the Focused Research Organization (FRO) model — a time-bound, technically ambitious non-profit structure that assembles teams of 10-30+ engineers and scientists to produce high-impact public goods (tools, datasets, platforms) that unblock progress in specific scientific fields over 3-7 year horizons. Convergent identifies scientific bottlenecks through systematic technical roadmapping, matches funders with founding teams, incubates FROs, and provides ongoing governance and operational support as a parent non-profit.

The organization has launched 10 FROs since 2021 spanning brain connectomics (E11 Bio, Forest Neurotech), proteomics (Parallel Squared Technology Institute), microbial cultivation (Cultivarium), pharmacology (EvE Bio), forensic immunology (Imprint), formal mathematics verification (Lean FRO), ocean carbon removal MRV ([C]Worthy), and UK-based brain connectivity and ecological intelligence (Meridial, Echo Labs). These FROs produce public goods including open-source software (plexDIA, Volara, Lean proof assistant, fUSI-BIDS), public datasets (EvE Bio Pharmome Data Portal, Cultivarium Organism Portal), and scientific infrastructure. Convergent's revenue model is philanthropic grant funding from 30+ individuals and institutions, with cumulative funding of approximately $400 million since inception. Funding tiers range from $10k for roadmapping support to $10M+ for anchoring new FROs, with FROs typically receiving initial grants of $20-50 million each.

Convergent Research firmographics

Firmographics
Name
Convergent Research
Legal name
Convergent Research, LLC
Website
https://convergentresearch.org
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
Convergent Research is a 501(c)(3) non-profit science studio that designs, launches, and operates Focused Research Organizations (FROs) — time-bound teams producing public-good tools, datasets, and platforms to unblock progress in specific scientific fields, funded by philanthropic grants.
Ownership category
akta.pro rank

Convergent Research industry classification

Industry
Product category
Scientific Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro primary industry
Research & Science Grantmaking Foundations (BPAGAKAI)
akta.pro secondary industries
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Sustainability & ESG Consulting (BPAHACAK)

Keywords

  • Scientific research infrastructure
  • Focused research organizations
  • Nonprofit science incubation
  • Open-source scientific tools
  • Public goods research

Where Convergent Research is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices7 records

Markets served

Convergent Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Philanthropic/Grant Funding: Convergent Research is a 501(c)(3) non-profit organization that raises funding from individuals and institutions to support FRO creation. Funding tiers include $10M+ to anchor a new FRO, $1M+ to co-fund an existing FRO with anchor donor, and $10k+ to support scientific roadmapping and FRO sourcing programs.
  2. FRO Operational Support: As a parent non-profit, Convergent provides subsidiary FROs with governance and critical operations support. FROs may generate revenue through product sales, perpetual endowment as foundation, or commercialization by licensing to companies.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Convergent Research product offering

Product offering

Core offering

Convergent Research is a nonprofit science studio that creates, funds, and operates Focused Research Organizations (FROs) — time-bound, technically ambitious nonprofit subsidiaries that build tools, datasets, and platforms as public goods to unblock scientific progress. The parent organization provides systematic technical roadmapping, founder-funder matchmaking, incubation, governance, and shared operational support to 10+ FROs across neuroscience, proteomics, microbiology, formal mathematics, immunology, climate science, and related fields.

Product overview

Convergent Research is a nonprofit science studio that pioneers the Focused Research Organization (FRO) model as a new operating system for science. Rather than a single unified product, Convergent Research serves as an incubator that designs, launches, and operates multiple subsidiary FROs (currently 10 active projects including Cultivarium, [C]Worthy, E11 Bio, EvE Bio, Forest Neurotech, Imprint, Lean FRO, and Parallel Squared Technology Institute). Each FRO is a time-bound nonprofit startup focused on building specific scientific infrastructure, tools, datasets, or platforms to remove bottlenecks in a particular scientific domain. Convergent provides operational backbone, governance, and fundraising support while FRO teams maintain technical focus and autonomy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cultivarium A bioengineering Focused Research Organization (FRO) that helps labs harness microorganisms through a predictive high-throughput culturing platform, cross-species genetic toolkit, and Microbe Information Hub indexing 170,000+ microbes. It produces public-good microbial cultivation tools and organism data for the scientific community.
  • E11 Bio A Focused Research Organization (FRO) building scalable technologies for circuit mapping at single-cell resolution in mammalian brains using PRISM technology, which combines protein barcoding, advanced microscopy, and machine learning for connectomics. It releases tools such as PRISMA (self-correcting neuron tracing) as open-source public goods.
  • Parallel Squared Technology Institute (PTI) A Focused Research Organization (FRO) accelerating single-cell proteomics using novel mass tags and multiplexing approaches to enable researchers to study thousands of individual cells in parallel. Produces open-source mass spectrometry tools and workflows (e.g., plexDIA, Volara) as public goods for proteomics researchers.
  • Forest Neurotech A Focused Research Organization (FRO) developing wearable whole-brain ultrasound technology for functional imaging and neuromodulation in humans, enabling non-invasive brain-computer interfaces. Releases tools such as fUSI-BIDS Pydantic as open-source public goods for neuroscience researchers.
  • Lean FRO A Focused Research Organization (FRO) working to make formal verification more accessible through the Lean programming language and proof assistant, with focus on scalability, usability, and proof automation. Releases the Lean proof assistant and a library of use cases as open-source public goods for the formal mathematics and verification community.
  • Imprint A Focused Research Organization (FRO) for forensic immunology, building experimental and machine learning tools to decode immune memory and identify hidden causes of chronic diseases including autoimmune, neurological, and psychiatric disorders. Located in New York.
  • EvE Bio A Focused Research Organization (FRO) mapping the pharmome by identifying all unintended targets (off-targets) of small-molecule pharmaceutical drugs through systematic drug-target assay results. Releases the Pharmome Data Portal as a CC BY-NC-SA-licensed public dataset updated by rolling releases.
  • [C]Worthy A Focused Research Organization (FRO) building open-source, science-backed tools for ocean-based carbon dioxide removal (CDR), including the C-Star platform for Monitoring, Reporting, and Verification (MRV) and the Ocean CDR Atlas. Works with commercial CDR companies, registries, and buyers.
  • Meridial A UK-based Focused Research Organization (FRO) building scientific infrastructure for living-brain connectivity mapping, launched in 2026 in partnership with the UK's ARIA agency.
  • Echo Labs A UK-based Focused Research Organization (FRO) building scientific infrastructure for ecological intelligence, launched in 2026 in partnership with the UK's ARIA agency.
  • Focused Research Organization (FRO) Model and Incubation Service Convergent Research's core offering: a systematic process for identifying scientific bottlenecks through technical roadmapping, matching funders and founders, and providing governance and operational support to launch time-bound, technically ambitious nonprofit FROs that produce high-impact public goods over 3-7 years. The methodology is itself the product that Convergent sells/delivers to scientists and funders.

Quantifiable outcome

  • Nearly $400 million secured from 30+ funders since 2021
  • +2 more outcomes

Companies that use Convergent Research

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Convergent Research technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Convergent Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ARIA (Advanced Research and Invention Agency)coreStrategic or Co-development Partner · 9 October 2025Convergent Research announced collaboration with UK-based ARIA as an Activation Partner to launch Focused Research Organizations (FROs) for science and technology in the UK ('FROST UK'). The partnership involves launching an open call for FRO proposals in spring 2025, selecting proposers for the Founder in Residence (FiR) program, and incubating at least one FRO in the UK. Convergent will work with ARIA's Program Directors to identify bottlenecks within their opportunity spaces.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Convergent Research competitors and assessment

Company assessment

Direct peers

  • Arc Institute: Palo Alto-based non-profit research organization founded in 2021 that runs large-scale, long-horizon team science initiatives with unrestricted funding from a small group of philanthropists (Patron, Cox, Pritzker). Closely comparable in mission, structure, and operating model to Convergent's FRO concept.
  • Schmidt Futures: Philanthropic venture led by Eric and Wendy Schmidt that funds ambitious science and talent programs, including Convergent itself. Directly comparable in deploying philanthropic capital toward frontier science infrastructure and scientist-led ventures.
  • UK Advanced Research and Invention Agency (ARIA): UK government R&D agency modeled on ARPA that funds high-risk, high-reward science through Program Directors. Active partner of Convergent for FROST UK and uses similar bottleneck-mapping and milestone-based funding approaches.
  • New Science: Non-profit focused on funding and scaling ambitious, unconventional scientific research and infrastructure, founded by Jan Chipchase. Directly comparable in operating in the gap between traditional academia, startups, and government science funding.
  • Federation of American Scientists (FAS): Non-profit policy and science organization that operates applied science projects and translates research into public-good outputs. Shares Convergent's model of housing technical programs under a non-profit umbrella to deliver public-impact science.
  • Arcadia Science: Non-profit research company founded by Patrick Collison that pursues high-risk, high-reward biology with a public-good orientation. Comparable in operating time-bound research programs with philanthropic funding and open science outputs.

Broad incumbents

  • Howard Hughes Medical Institute (HHMI): Large, established non-profit biomedical research organization that funds and operates labs to produce scientific public goods. Comparable in mission to produce research as public good, but operates at much larger scale and focuses exclusively on biomedical research.
  • Open Philanthropy: Major philanthropic funder backing high-impact, long-horizon science causes including Convergent itself. Comparable as a large-scale science-philanthropy organization but operates as a grantmaker rather than as an operating R&D entity.
  • Allen Institute: Paul Allen-founded non-profit research institutes (AI, brain science, cell science) that operate large team-science programs producing public-good datasets and tools. Comparable in mission and open-data outputs but is larger, longer-established, and domain-focused rather than diversified like Convergent's FRO portfolio.

Emerging players

  • Renaissance Philanthropy: Non-profit philanthropy organization led by Tom Kalil (Convergent board chair) focused on increasing R&D investment for scientific and technological progress. Conceptually adjacent in deploying philanthropic capital toward science infrastructure priorities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Convergent Research social profiles

Digital presence

Convergent Research compliance and trust

Trust signal

Compliance2 records

Convergent Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Convergent Research leadership team

Management profile

Number of profiles

Profiles7 records

Convergent Research subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

Convergent Research funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Convergent Research M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Convergent Research

What does Convergent Research do?

Convergent Research is a nonprofit science studio that creates, funds, and operates Focused Research Organizations (FROs) — time-bound, technically ambitious nonprofit subsidiaries that build tools, datasets, and platforms as public goods to unblock scientific progress. The parent organization provides systematic technical roadmapping, founder-funder matchmaking, incubation, governance, and shared operational support to 10+ FROs across neuroscience, proteomics, microbiology, formal mathematics, immunology, climate science, and related fields.

Is Convergent Research a public or private company?

Convergent Research is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Convergent Research founded?

Convergent Research was founded in 2021. It employs 51 to 100 people.

Where is Convergent Research based?

Convergent Research is headquartered in Palo Alto, United States, in the North America region.

How does Convergent Research make money?

Two revenue lines are on record. Philanthropic/Grant Funding is the primary driver. The others are FRO Operational Support.

Who are Convergent Research's main competitors?

Direct peers on record are Arc Institute, Schmidt Futures, UK Advanced Research and Invention Agency (ARIA), New Science, Federation of American Scientists (FAS) and Arcadia Science. Broad incumbents are Howard Hughes Medical Institute (HHMI), Open Philanthropy and Allen Institute. Renaissance Philanthropy is listed as an emerging player.

Does Convergent Research have an API?

No public API is recorded for Convergent Research.

What industry is Convergent Research in?

Convergent Research's product category is Scientific Research Services. Its primary akta.pro industry code is BPAGAKAI, Research & Science Grantmaking Foundations, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureMeeting the moment: how scientific philanthropies are expanding their reachScientific philanthropies are expanding their reach to fill gaps left by US federal funding cuts that terminated over 2,200 research grants totalling $2.5 billion in 2025. Organizations including the Gordon and Betty Moore Foundation deployed $55 million to 30 universities to support roughly 400 postdocs, while the Science Philanthropy Alliance grew to 45 member organizations. The sector is adopting venture philanthropy models, with Convergent Research launching focused research organizations backed by tens of millions from Eric and Wendy Schmidt, and partnerships with the UK Advanced Research and Invention Agency to develop promising proposals.PR NewswireConvergent Research and ARIA Launch Two New UK Focused Research OrganizationsConvergent Research and ARIA have announced the launch of two new UK Focused Research Organizations (FROs): Meridial and Echo Labs. The FROs aim to build scientific infrastructure for living-brain connectivity mapping and ecological intelligence. This model represents a new approach to establishing scientific institutions around technical bottlenecks that are too engineering-heavy, operationally complex, or long-horizon for conventional labs or startups.AsteriskmagThe Fight For Slow And Boring ResearchThis opinion piece argues that academic research labs must improve their science communication to attract diverse non-federal funding, as philanthropists and hybrid funders increasingly evaluate researchers on clarity and public legibility alongside scientific merit. The article presents alternative research organizations such as Arc Institute ($650M+ committed funding), Arcadia Science ($500M), and Convergent Research's Focused Research Organizations as models for packaging basic research accessibly while preserving its depth and rigor. The author contends that universities should learn from both commercial startups and these emerging research models to keep slow, foundational work funded without requiring it to compete on the same terms as near-term applications.Chan Zuckerberg Initiative6 Breakthrough Climate Research Initiatives2023 has been reported as the hottest year on record according to a NASA analysis, with global temperatures expected to rise 1.5 degrees Celsius by the early 2030s. A concerted global effort is underway to mitigate climate change through innovative technologies for carbon removal, with organizations like the Massachusetts Institute of Technology and Convergent Research leading significant initiatives. Experts emphasize the need for technological advancements and investments to meet climate goals.Business Wire BlogConvergent Research Announces Major New Funding Commitment to Forest NeurotechConvergent Research announced a $14 million funding commitment from Eric Schmidt to Forest Neurotech, which develops an ultrasound-based brain-computer interface. The initiative also received funding from Griffin Catalyst, the Riley & Susan Bechtel Foundation, and James Fickel. The technology aims to provide minimally invasive diagnostics and therapeutics for neurological conditions.BioSpaceConvergent Research Announces Major New Funding Commitment to Forest NeurotechConvergent Research announced a $14 million funding commitment to Forest Neurotech, an initiative aimed at developing next-generation brain-computer interfaces using ultrasound technology. The funding is provided by former Google CEO Eric Schmidt, with additional support from Griffin Catalyst and other foundations. This investment supports Forest Neurotech's development of minimally invasive diagnostic and therapeutic tools for neurological conditions.SloanConvergent ResearchConvergent Research, backed by Schmidt Futures, is launching a Focused Research Organization (FRO) led by Leonardo de Moura to improve the Lean proof assistant software. This initiative aims to address sustainability and automation challenges in mathematical verification through a dedicated nonprofit structure. The project seeks to establish a long-term Lean Foundation to support the tool's continued development and adoption.